Clinical Trial Update: Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical and pharmacological study of 2B3-101 in patients with breast cancer and leptomeningeal metastases; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Leptomeningeal Metastasis

Drugs mentioned

• 2B3-101

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Meningeal Carcinomatosis | Phase 2 | Status: UNKNOWN